These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19414982)

  • 1. The effects of short-term, rapid glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia.
    Norlinah MI; Hamizah R; Md Isa SH; Wan Nazaimoon WM; Khalid BA
    Indian J Med Sci; 2009 Apr; 63(4):131-8. PubMed ID: 19414982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glycemic control and aldose reductase inhibition on nerve conduction velocity.
    Pfeifer MA
    Am J Med; 1985 Nov; 79(5A):18-23. PubMed ID: 3934964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial.
    Ng YT; Phang SCW; Tan GCJ; Ng EY; Botross Henien NP; M Palanisamy UD; Ahmad B; Abdul Kadir K
    Nutrients; 2020 May; 12(5):. PubMed ID: 32456230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.
    Sakharova OV; Lleva RR; Dziura JD; Spollett GR; Howell SK; Beisswenger PJ; Inzucchi SE
    J Diabetes Complications; 2012; 26(4):333-8. PubMed ID: 22541894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.
    Ponirakis G; Abdul-Ghani MA; Jayyousi A; Zirie MA; Al-Mohannadi S; Almuhannadi H; Petropoulos IN; Khan A; Gad H; Migahid O; Megahed A; Qazi M; AlMarri F; Al-Khayat F; Mahfoud Z; DeFronzo R; Malik RA
    J Diabetes Investig; 2021 Nov; 12(11):2002-2009. PubMed ID: 34002953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.
    Graf RJ; Halter JB; Pfeifer MA; Halar E; Brozovich F; Porte D
    Ann Intern Med; 1981 Mar; 94(3):307-11. PubMed ID: 7013592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial.
    Weiss SR; Cheng SL; Kourides IA; Gelfand RA; Landschulz WH;
    Arch Intern Med; 2003 Oct; 163(19):2277-82. PubMed ID: 14581245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes.
    Ryysy L; Yki-Järvinen H
    Diabetes Care; 2001 Mar; 24(3):549-54. PubMed ID: 11289483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
    Bril V; Buchanan RA
    Diabetes Care; 2006 Jan; 29(1):68-72. PubMed ID: 16373898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.
    Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L
    J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patients.
    Huang CC; Chen TW; Weng MC; Lee CL; Tseng HC; Huang MH
    Kaohsiung J Med Sci; 2005 Jan; 21(1):15-21. PubMed ID: 15754584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in C-reactive protein and advanced glycosylation end-products in poorly controlled diabetics is independent of glucose control.
    Md Isa SH; Najihah I; Nazaimoon WM; Kamarudin NA; Umar NA; Mat NH; Khalid BA
    Diabetes Res Clin Pract; 2006 Apr; 72(1):48-52. PubMed ID: 16253380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral versus peroneal neuropathy in diabetic children and adolescents--relationships to clinical status, metabolic control and retinopathy.
    Kruger M; Brunko E; Dorchy H; Noël P
    Diabete Metab; 1987 Apr; 13(2):110-5. PubMed ID: 3595967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.